We are live on ! Find out more
RERE

ATRenew

51 hedge funds and large institutions have $126M invested in ATRenew in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 7

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

46% more capital invested

Capital invested by funds: $86.7M → $126M (+$39.6M)

19% more funds holding

Funds holding: 43 → 51 (+8)

5.37% more ownership

Funds ownership: 14.41% → 19.78% (+5.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
51
Holders Change
+8
Holders Change %
+18.6%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
17
Increased
20
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

RERE Hedge Fund Activity: Q4 2024 in Review

51 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in ATRenew (RERE) for Q4 2024, worth a combined $126M — up 46% from $86.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new RERE positions and 9 closed out — a net gain of 8 holders — while 20 added to existing stakes and 7 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $6.4M. The largest seller was Barclays, cutting an estimated $1.3M.

  • 51 institutional investors held ATRenew (RERE) as of Q4 2024, up from 43 in Q3 2024.
  • Funds reported $126M of ATRenew stock for Q4 2024, up 46% quarter-over-quarter.
  • 17 funds opened new ATRenew positions in Q4 2024 and 9 closed out, a net change of +8 holders.
  • The largest ATRenew buyer in Q4 2024 was T. Rowe Price Associates, an estimated $6.4M added.
  • The largest ATRenew seller in Q4 2024 was Barclays, an estimated $1.3M sold.

Based on aggregated 13F filings for Q4 2024.